Categories: Manufacturers (D)

Ishita Drugs & Industries Limited, 401, 3rd Eye II, Opp Parimal Garden, C.G. Road, Ahmedabad 380006 (Gujarat), India

Company Name: Ishita Drugs & Industries Limited

Address: 401, 3rd Eye II, Opp Parimal Garden, C.G. Road, Ahmedabad 380006 (Gujarat), India

Tel No: 91 79 2646 8353 / 7886

Email : info@ishitadrugs.com, sales@ishitadrugs.com

Website: http://www.ishitadrugs.com/

Company Profile

Incorporated in 1992, ISHITA DRUGS & INDUSTRIES LIMITED (IDIL) is the flagship company of ISHITA group. IDIL is a public limited company, listed on the domestic stock exchanges (BSE and ASE). The setting up of IDIL was a major landmark in the history of the ISHITA group and is even today a key growth driver for the entire group.

IDIL is an ISO 9001:2008 certified company by AGSI. It has also been assigned a credit rating of SE2A by D&B, indicating high performance capability and high financial strength (D-U-N-S Number 65-018-0359.

IDIL is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipients. It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms. The plant is regularly audited and approved by various regulatory authorities as well as leading pharma companies, who are our customers.

The Pharma Times News Bureau

Recent Posts

The future of healthcare: Five key trends for providers in 2025

By Srinath Rao, Senior Vice President, CitiusTech A few decades back, the purpose of watches…

1 day ago

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

Pharmapack Europe: 'Basel the best location for drug device innovation in Europe thanks to combination…

1 day ago

Quote on HMPV by Doctors of Super Specialty Hospitals

New Delhi, January 07, 2025: HMP virus can travel to the brain, or it can…

2 days ago

Advisory For Hmpv – Key Preventative Measures

~ Co-authored by Dr Sanjith Saseedharan, Director-Critical Care, S. L. Raheja Hospital- A Fortis Associate…

2 days ago

40% of Doctor Appointments Dedicated to Family and Friends, Reveals MediBuddy’s 2024 Data

Patients Embrace Flexibility with 37% of Online Doctor Consultations now happening even After 6 PM,…

3 days ago

American Institute of Pathology & Laboratory Sciences (Ampath) in Collaboration Expands its Diagnostic Services in Uttar Pradesh

Launches Advanced Pathology Laboratory Offering Over 2500+ Tests in collaboration with Parashar Pathology Clinic in…

3 days ago